Luye Pharma Group Ltd. (LYPHF)

PNK: LYPHF · Real-Time Price · USD

0.27

0.01 (5.80%)

At close: Apr 29, 2025, 9:30 AM

Luye Pharma Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.24B	2.32B	2.44B	3.87B	2.33B	1.67B	1.27B	397.77M
Short-Term Investments	1.27B	3.22B	3.07B	1.54B	2.86B	3.19B	2.58B	2.35B
Long-Term Investments	696.74M	-2.11B	-2.49B	-1.47B	-2.79B	-3.11B	-2.53B	-2.34B
Other Long-Term Assets	3.16B	3.56B	3.52B	1.85B	2.91B	3.19B	2.58B	2.35B
Receivables	2.59B	1.78B	1.77B	1.55B	1.81B	1.53B	1.41B	1.42B
Inventory	827.86M	772.94M	746.34M	612.3M	614.62M	585.61M	420.36M	452.67M
Other Current Assets	1.07B	2.22B	2.37B	2.31B	3.16B	3.03B	1.69B	1.21B
Total Current Assets	10.7B	10.79B	10.4B	9.97B	9.36B	8.68B	6.3B	5.28B
Property-Plant & Equipment	5.09B	4.91B	4.59B	4.34B	4.21B	3.2B	2.46B	1.97B
Goodwill & Intangibles	5.85B	6.99B	6.43B	5.83B	5.52B	5.49B	1.87B	1.85B
Total Long-Term Assets	14.79B	13.46B	12.19B	10.66B	9.95B	8.86B	4.46B	3.92B
Total Assets	25.49B	24.25B	22.58B	20.63B	19.31B	17.54B	10.76B	9.21B
Account Payables	767.19M	559.94M	570.89M	485.26M	341.05M	279.75M	104.6M	116.14M
Deferred Revenue	n/a	n/a	n/a	n/a	1.29B	223.84M	631.24M	629.5M
Short-Term Debt	5.18B	6.82B	5.24B	5.63B	4.02B	5.29B	2.86B	1.62B
Other Current Liabilities	1.43B	1.4B	1.07B	895.51M	819.29M	2.03B	-192.41M	-191.28M
Total Current Liabilities	8.14B	9.49B	7.33B	7.23B	5.55B	8.2B	3.65B	2.37B
Long-Term Debt	3.18B	2.24B	4.21B	4.33B	4.5B	847.51M	n/a	n/a
Other Long-Term Liabilities	596.22M	1.46B	1.91B	958.81M	-114.68M	554.25M	209.46M	n/a
Total Long-Term Liabilities	3.82B	3.72B	6.14B	5.3B	4.4B	1.4B	209.69M	269.07M
Total Liabilities	11.96B	13.21B	13.47B	12.53B	9.94B	9.6B	3.86B	2.64B
Total Debt	8.42B	9.1B	9.49B	9.98B	8.07B	6.14B	2.86B	1.62B
Common Stock	486.11M	456.95M	455.83M	417.99M	420.56M	421.34M	427.27M	427.27M
Retained Earnings	7.38B	6.67B	6.06B	6.21B	5.69B	4.84B	3.81B	2.67B
Comprehensive Income	505.21M	254.46M	534.04M	501.52M	381.88M	-888.71M	-735.07M	-592.79M
Shareholders Equity	12.53B	10.18B	8.49B	7.89B	9.22B	7.81B	6.77B	6.43B
Total Investments	1.97B	1.11B	582.2M	71.46M	71.87M	83.57M	40.81M	8.49M